JY
NUVB icon

Jeff Yass’s Nuvation Bio NUVB Stock Holding History

Jeff Yass’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.2M Buy
914,779
+771,166
+537% +$3.77M ﹤0.01% 4539
2026
Q1 		$616K Buy
143,613
+127,751
+805% +$712K ﹤0.01% 9119
2025
Q4 		$142K Sell
15,862
-802,917
-98% -$4.97M ﹤0.01% 11218
2025
Q3 		$3.03M Buy
818,779
+423,240
+107% +$1.15M ﹤0.01% 4957
2025
Q2 		$771K Buy
395,539
+146,458
+59% +$305K ﹤0.01% 8110
2025
Q1 		$438K Buy
249,081
+168,419
+209% +$383K ﹤0.01% 9185
2024
Q4 		$215K Buy
80,662
+66,177
+457% +$170K ﹤0.01% 10580
2024
Q3 		$33.2K Sell
14,485
-5,814
-29% -$17.7K ﹤0.01% 11511
2024
Q2 		$59.3K Buy
+20,299
New +$61.9K ﹤0.01% 11335
2024
Q1 		– Sell
-154,083
Closed -$233K – 12967
2023
Q4 		$233K Buy
154,083
+139,861
+983% +$180K ﹤0.01% 10365
2023
Q3 		$19.1K Sell
14,222
-31,881
-69% -$53.1K ﹤0.01% 11616
2023
Q2 		$83K Sell
46,103
-72,456
-61% -$123K ﹤0.01% 11083
2023
Q1 		$197K Buy
118,559
+93,186
+367% +$189K ﹤0.01% 10614
2022
Q4 		$48.7K Sell
25,373
-50,298
-66% -$102K ﹤0.01% 11412
2022
Q3 		$170K Buy
+75,671
New +$216K ﹤0.01% 11075
2022
Q2 		– Sell
-11,827
Closed -$62K – 13607
2022
Q1 		$62K Sell
11,827
-48,358
-80% -$272K ﹤0.01% 12210
2021
Q4 		$512K Buy
60,185
+37,566
+166% +$345K ﹤0.01% 9138
2021
Q3 		$225K Sell
22,619
-49,806
-69% -$451K ﹤0.01% 11224
2021
Q2 		$674K Buy
72,425
+39,287
+119% +$448K ﹤0.01% 8838
2021
Q1 		$346K Buy
+33,138
New +$371K ﹤0.01% 10316

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jeff Yass's NUVB Position: Q2 2026 in Review

Jeff Yass increased its Nuvation Bio (NUVB) stake by 537% in Q2 2026, buying an estimated $3.77M and bringing the position to 914,779 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #4539.

Jeff Yass first reported a position in NUVB in Q1 2021 and has held it in 20 quarters since. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Jeff Yass held 914,779 shares of Nuvation Bio worth $5.2M as of Q2 2026.
  • Jeff Yass bought 771,166 Nuvation Bio shares in Q2 2026, an estimated $3.77M.
  • Nuvation Bio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4539 holding.
  • Jeff Yass first reported a position in Nuvation Bio in Q1 2021 and has held it in 20 quarters since.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.